EBM Technologies (ROCO:8409) ROE %: 34.58% (As of Dec. 2025)


ROCO:8409 EBM Technologies Inc ROCO:8409
64 GF Score
Price NT$19.10
GF Value NT$25.74
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is EBM Technologies ROE %?

EBM Technologies ROCO:8409 64 ROE % is 34.58% as of Dec. 2025. GuruFocus rates ROCO:8409 with a GF Score™ of 64/100 and a GF Value™ of NT$25.74 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 624 Healthcare Providers & Services companies, EBM Technologies ranks worse than 59.78% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. EBM Technologies's annualized net income for the quarter that ended in Dec. 2025 was NT$105.4 Mil. EBM Technologies's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was NT$304.7 Mil. Therefore, EBM Technologies's annualized ROE % for the quarter that ended in Dec. 2025 was 34.58%.

The historical rank and industry rank for EBM Technologies's ROE % or its related term are showing as below:

ROCO:8409' s ROE % Range Over the Past 10 Years
Min: -14.63   Med: -4.53   Max: 2.64
Current: 2.64

During the past 13 years, EBM Technologies's highest ROE % was 2.64%. The lowest was -14.63%. And the median was -4.53%.

ROCO:8409's ROE % is ranked worse than
59.78% of 624 companies
in the Healthcare Providers & Services industry
Industry Median: 5.85 vs ROCO:8409: 2.64

EBM Technologies  (ROCO:8409) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=105.376/304.7015
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(105.376 / 330.928)*(330.928 / 438.2935)*(438.2935 / 304.7015)
=Net Margin %*Asset Turnover*Equity Multiplier
=31.84 %*0.755*1.4384
=ROA %*Equity Multiplier
=24.04 %*1.4384
=34.58 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=105.376/304.7015
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (105.376 / 129.5) * (129.5 / 124.604) * (124.604 / 330.928) * (330.928 / 438.2935) * (438.2935 / 304.7015)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.8137 * 1.0393 * 37.65 % * 0.755 * 1.4384
=34.58 %

Note: The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


EBM Technologies ROE % Related Terms


EBM Technologies ROE % Historical Data

* Premium members only.

The historical data trend for EBM Technologies's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EBM Technologies ROE % Chart

EBM Technologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.49 1.27 -4.47 0.69 2.47

EBM Technologies Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.44 -33.14 -28.93 38.22 34.58

ROCO:8409 vs VEEV, BTSG, TEM: ROE % Comparison

For the Health Information Services subindustry, EBM Technologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EBM Technologies ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EBM Technologies's ROE % distribution charts can be found below:

* The bar in red indicates where EBM Technologies's ROE % falls into.


ROCO:8409
64GF Score
EBM Technologies Inc ROCO:8409
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EBM Technologies ROE % Calculation

EBM Technologies's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=7.798/( (313.453+318.97)/ 2 )
=7.798/316.2115
=2.47 %

EBM Technologies's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Sep. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=105.376/( (290.433+318.97)/ 2 )
=105.376/304.7015
=34.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 34.58% mean?
EBM Technologies (ROCO:8409) has a ROE % of 34.58% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on EBM Technologies and its competitors. According to the industry distribution chart, EBM Technologies ranks #373 out of 624 companies in the Healthcare Providers & Services industry, placing it in the top 59.8%.
Is EBM Technologies' ROE % too high?
EBM Technologies' current ROE % is 34.58%. The Healthcare Providers & Services industry median ROE % is 5.85. EBM Technologies' value of 34.58% is 491.1% above this industry median. Based on the distribution chart, EBM Technologies ranks #373 out of 624 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, EBM Technologies has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EBM Technologies' ROE % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, EBM Technologies ranks #373 out of 624 companies for ROE %. This places EBM Technologies in the lower half of its industry. The industry median ROE % is 5.85. EBM Technologies' value of 34.58% is 491.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.85, based on 624 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. EBM Technologies's current ROE % of 34.58% is 491.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on EBM Technologies and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EBM Technologies's current ROE % is 34.58%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EBM Technologies stock overvalued right now?
Based on GuruFocus' analysis, EBM Technologies (ROCO:8409) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$25.74, compared to a current price of NT$19.10 — trading 25.8% below its estimated fair value. The current ROE % is 34.58% and 491.1% above the Healthcare Providers & Services industry median of 5.85. EBM Technologies' overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For EBM Technologies (ROCO:8409), the current ROE % is 34.58% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EBM Technologies (ROCO:8409) Overvalued in 2026?

Based on GuruFocus' analysis, EBM Technologies stock appears to be undervalued. The current stock price of NT$19.10 is trading 25.8% below its estimated GF Value™ of NT$25.74. GuruFocus considers EBM Technologies to be Modestly Undervalued.

Key valuation signals for ROCO:8409:

  • ROE %: 34.58%
  • GF Value™: NT$25.74 vs. price of NT$19.10 (25.8% below fair value)
  • GF Score™: 64/100 with 4 warning signs
  • Industry Position: 491.1% above the Healthcare Providers & Services median (#373 of 624)

No single metric tells the full story. See the ROCO:8409 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


EBM Technologies Business Description

Address No. 516, Sec 1, Neihu Road, 5th floor, Neihu District, Taipei, TWN
EBM Technologies Inc is engaged in picture archiving and communication systems. Its products include EBM diagnostic and reviewing station, EBM storage and utility server, and EBM breast imaging for PACS. The company develops and markets medical information technology solutions; and provides to the health sector.
64GF Score

Get the complete analysis for ROCO:8409

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$19.10
Price
NT$25.74
GF Value